| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 109.40M | 107.45M | 101.01M | 126.56M | 126.01M |
| Gross Profit | 32.63M | 30.85M | 23.31M | 27.62M | 29.01M |
| EBITDA | 9.96M | 11.06M | 2.60M | 10.07M | 9.15M |
| Net Income | 7.10M | 2.51M | -1.62M | 4.58M | 3.81M |
Balance Sheet | |||||
| Total Assets | 78.40M | 68.49M | 70.74M | 80.37M | 105.89M |
| Cash, Cash Equivalents and Short-Term Investments | 32.73M | 19.44M | 20.10M | 15.32M | 17.63M |
| Total Debt | 420.94K | 6.67M | 15.51M | 25.49M | 25.82M |
| Total Liabilities | 33.54M | 43.32M | 47.92M | 56.06M | 84.32M |
| Stockholders Equity | 44.86M | 25.17M | 22.81M | 24.30M | 21.57M |
Cash Flow | |||||
| Free Cash Flow | 7.17M | 13.24M | 13.26M | 297.00K | 1.35M |
| Operating Cash Flow | 7.82M | 14.21M | 14.07M | 1.39M | 3.60M |
| Investing Cash Flow | -597.00K | -928.00K | -724.00K | 531.00K | -1.47M |
| Financing Cash Flow | 5.61M | -10.39M | -11.85M | -4.08M | -6.79M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$39.78B | 4.66 | 17.22% | 2.96% | 15.36% | 42.66% | |
65 Neutral | HK$791.68B | 35.74 | 16.26% | ― | 25.04% | 71.31% | |
62 Neutral | HK$2.29B | 34.44 | 19.27% | 0.50% | 1.72% | 180.88% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
54 Neutral | HK$265.72M | -22.59 | -11.38% | 8.70% | -16.95% | -461.16% | |
48 Neutral | HK$11.27B | 8.83 | 1.98% | ― | 8.16% | -26.27% | |
46 Neutral | HK$258.91M | -2.82 | -13.04% | ― | -45.30% | 53.12% |